Literature DB >> 23066889

Diabetes mellitus and cancer risk: review of the epidemiological evidence.

Kentaro Shikata1, Toshiharu Ninomiya, Yutaka Kiyohara.   

Abstract

Diabetes mellitus and cancer are diseases of epidemic proportions across the globe. These diseases are influenced by many factors, both genetic and environmental. A possible association between diabetes and cancer risk has long been speculated. Increased incidence of several cancers has been observed in diabetes patients, notably pancreatic, hepatic, colorectal, breast, urinary tract, and endometrial cancers. In contrast, a decreased incidence of prostate cancer is observed in diabetes patients, implying a protective effect. Precise knowledge of the complex associations and interactions between these two conditions is of great importance for their prevention and treatment. Multiple potential mechanisms have been proposed, but they have tended to be site-specific. Possible common mechanisms for a biological link between diabetes and cancer include hyperinsulinemia, hyperglycemia, and inflammation. Today, 366 million people live with diabetes globally, and this figure is expected to increase. Thus, if diabetes is associated with even a small increase in cancer risk, this may have important consequences at the population level. The aim of this review is to summarize recent epidemiological evidence of an association between diabetes and total cancer and specific sites of cancer, and to consider causal associations between these diseases.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Year:  2012        PMID: 23066889     DOI: 10.1111/cas.12043

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  94 in total

1.  Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.

Authors:  J Zhang; X Qin; Q Sun; H Guo; X Wu; F Xie; Q Xu; M Yan; J Liu; Z Han; W Chen
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

2.  Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer.

Authors:  Akira Sekikawa; Hirokazu Fukui; Ryota Sada; Manabu Fukuhara; Saiko Marui; Gensho Tanke; Masatsugu Endo; Yoshiaki Ohara; Fumihiro Matsuda; Jun Nakajima; Shinichiro Henmi; Sumio Saito; Takehiko Tsumura; Takanori Maruo; Toru Kimura; Yukio Osaki
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

3.  Influence of socioeconomic events on cause-specific mortality in urban Shanghai, China, from 1974 to 2015: a population-based longitudinal study.

Authors:  Shuo Wang; Xiaoyu Du; Xue Han; Fan Yang; Jia Zhao; Hui Li; Mi Li; Hongwei Zhang; Wenbin Liu; Jiahui Song; Guangwen Cao
Journal:  CMAJ       Date:  2018-10-01       Impact factor: 8.262

4.  Carbohydrate nutrition and risk of adiposity-related cancers: results from the Framingham Offspring cohort (1991-2013).

Authors:  Nour Makarem; Elisa V Bandera; Yong Lin; Paul F Jacques; Richard B Hayes; Niyati Parekh
Journal:  Br J Nutr       Date:  2017-06-29       Impact factor: 3.718

5.  Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.

Authors:  K Takano; S Fuji; N Uchida; H Ogawa; K Ohashi; T Eto; H Sakamaki; Y Morishima; K Kato; R Suzuki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

6.  Association between autoimmune pancreatitis and malignancy.

Authors:  Kenji Hirano; Hiroyuki Isayama; Minoru Tada; Kazuhiko Koike
Journal:  Clin J Gastroenterol       Date:  2014-04-18

7.  Vitamin D supplementation for prevention of cancer: The D2d cancer outcomes (D2dCA) study.

Authors:  Ranee Chatterjee; John K Erban; Paul Fuss; Rowena Dolor; Erin LeBlanc; Myrlene Staten; Patricia Sheehan; Anastassios Pittas
Journal:  Contemp Clin Trials       Date:  2019-04-29       Impact factor: 2.226

Review 8.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

9.  Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer.

Authors:  Naoto Yamamoto; Takashi Oshima; Kazue Yoshihara; Toru Aoyama; Tsutomu Hayashi; Takanobu Yamada; Tsutomu Sato; Manabu Shiozawa; Takaki Yoshikawa; Soichiro Morinaga; Yasushi Rino; Chikara Kunisaki; Katsuaki Tanaka; Makoto Akaike; Toshio Imada; Munetaka Masuda
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

Review 10.  Colorectal cancer screening: 20 years of development and recent progress.

Authors:  Miroslav Zavoral; Stepan Suchanek; Ondrej Majek; Premysl Fric; Petra Minarikova; Marek Minarik; Bohumil Seifert; Ladislav Dusek
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.